Pioglitazone Attenuates Atherosclerotic Plaque Inflammation in Patients With Impaired Glucose Tolerance or Diabetes | Zendy

Minori Mizoguchi | Zendy; Nobuhiro Tahara | Zendy; Atsuko Tahara | Zendy; Yoshikazu Nitta | Zendy; Norihiro Kodama | Zendy; Toyoharu Oba | Zendy; Kazutoshi Mawatari | Zendy; Hideo Yasukawa | Zendy; Hayato Kaida | Zendy; Masatoshi Ishibashi | Zendy; Naofumi Hayabuchi | Zendy; Haruhito Harada | Zendy; Hisao Ikeda | Zendy; Shoichi Yamagishi | Zendy; Tsutomu Imaizumi | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Pioglitazone Attenuates Atherosclerotic Plaque Inflammation in Patients With Impaired Glucose Tolerance or Diabetes

Author(s) -

Minori Mizoguchi,

Nobuhiro Tahara,

Atsuko Tahara,

Yoshikazu Nitta,

Norihiro Kodama,

Toyoharu Oba,

Kazutoshi Mawatari,

Hideo Yasukawa,

Hayato Kaida,

Masatoshi Ishibashi,

Naofumi Hayabuchi,

Haruhito Harada,

Hisao Ikeda,

Shoichi Yamagishi,

Tsutomu Imaizumi

Publication year - 2011

Publication title -

jacc. cardiovascular imaging

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 5.79

H-Index - 120

eISSN - 1936-878X

pISSN - 1876-7591

DOI - 10.1016/j.jcmg.2011.08.007

Subject(s) - pioglitazone , glimepiride , medicine , inflammation , diabetes mellitus , endocrinology , type 2 diabetes , gastroenterology

The aim of this study was to compare the effect of pioglitazone, an insulin sensitizer, with glimepiride, an insulin secretagogue, on atherosclerotic plaque inflammation by using serial (18)F-fluorodeoxyglucose positron emission tomography (FDG-PET) imaging.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research